109631 ⎘
dsDNA viruses; Details; Adenoviridae Demonstrated effect
PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF
#2VIRAL DELIVERY OF NEOANTIGENS
#3VIRUS ENCODING TRANSGENES TO COMPLEMENT CELLULAR THERAPY
#4ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
#5IMMUNOEVASIVE ANTI-TUMOR ADENOVIRUS
#6Therapeutic pharmaceutical composition for bone and soft tissue tumors
#7ADENOVIRUS FOR TREATMENT OF CANCER
#8ADENOVIRAL GENE THERAPY VECTORS
#9CHIMERIC ADENOVIRAL VECTORS
#10VIRAL DELIVERY OF NEOANTIGENS
#11RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS
#12NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN PANCREATIC TROPISM
#13REPLICATION-DEFICIENT ADENOVIRUS
#14RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION
#15PREPARATION METHOD FOR ANIMAL MODEL OF ALZHEIMER'S DISEASE AND ANIMAL MODEL OF ALZHEIMER'S DISEASE PREPARED BY THE SAME
#16Methods of vaccine administration
#17MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS
#18COMBINATION IMMUNOTHERAPY
#19DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES
#20ADENOVIRUS LIBRARY AND METHODS
#21Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor
#22Replication-enhanced oncolytic adenoviruses
#23PSMA-based molecular-genetic reporter system
#24Methods of vaccine administration
#25Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism
#26Adenovirus library and methods
#27VIRAL DELIVERY OF NEOANTIGENS
#28ANTICANCER COMPOSITION COMPRISING RECOMBINANT ADENOVIRUS EXPRESSING DEGRADATION FACTOR FOR EXTRACELLULAR MATRIX
#29METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#30METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#31Methods for inducing migration by dendritic cells and an immune response
#32Modified interleukin 12 and use thereof in preparing drugs for treating tumours
#33METHODS FOR TREATMENT OF CANCER
#34Combination immunotherapy
#35Methods and compositions for combination immunotherapy
#36Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#37Anti-tumor medicament based on adenovirus
#38Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#39Regeneration of Inner Ear Cells
#40PSMA-based molecular-genetic reporter system
#41Splice variants of GDNF and uses thereof
#42Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
#43FRAGILE HISTIDINE TRIAD (FHIT) COMPOSITIONS AND USES THEREOF
#44R-SPONDIN ANTAGONISTS AND METHODS OF TREATING CANCER ASSOCIATED WITH ABERRANT ACTIVATION OF WNT SIGNALING
#45Pharmaceutical composition for preventing and treating cancer, containing CYB5R3 gene or protein as active ingredient
#46Materials and methods for the treatment of pathological neovascularization in the eye
#47Dosing regime and formulations for type B adenovirus
#48WNT MODULATORS FOR THE PROTECTION, MITIGATION AND TREATMENT OF RADIATION INJURY
#49Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#50SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
#51Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
#52METHOD AND COMPOSITION FOR TREATING SPASTICITY
#53ONCOLYTIC VIRUS ENCODING PD-1 BINDING AGENTS AND USES OF THE SAME
#54Methods of vaccine administration
#55Methods for inducing migration by dendritic cells and an immune response
#56Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
#57Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#58Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
#59Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#60Pharmaceutical Composition and Method for the Treatment of Neurodegenerative Diseases, in Particular Amyotrophic Lateral Sclerosis
#61Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis
#62Compositions and methods for inducing migration by dendritic cells and an immune response
#63VIRUS-MEDIATED DELIVERY OF BEVACIZUMAB FOR THERAPEUTIC APPLICATIONS
#64Adenovirus library and methods
#65Materials and methods for the treatment of pathological neovascularization in the eye
#66Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
#67METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#68Splice variants of GDNF and uses thereof
#69Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin
#70METHODS OF VACCINE ADMINISTRATION
#71Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#72Compositions and Methods for Treatment of Vascular Grafts
#73Method for augmenting vision in persons suffering from photoreceptor cell degeneration